8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Mar 10, 2026·SEC
Material company update
Feb 5, 2026·SEC
Encompass Health Corporation(EHC)Earnings, Financials & Key Ratios
EHC•NYSE
17.7× P/E·Price updated Jun 19, 2026
AboutEncompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.Show more
- Revenue$5.94B+10.5%
- EBITDA$1.38B+18.6%
- Net Income$566M+24.2%
- EPS (Diluted)5.54+24.2%
- Gross Margin95.71%+130.3%
- EBITDA Margin23.27%+7.4%
- Operating Margin17.74%+10.3%
- Net Margin9.54%+12.5%
- ROE18.49%+4.4%
EHC Key Insights
Encompass Health Corporation (EHC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 9/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 10.7%
- ✓Good 3Y average ROE of 17.7%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when EHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
EHC Price & Volume
Encompass Health Corporation (EHC) stock price & volume — 10-year historical chart
Loading chart...
EHC Growth Metrics
Encompass Health Corporation (EHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.66%
5 Years10.72%
3 Years10.92%
TTM10.05%
Profit CAGR
10 Years11.95%
5 Years14.78%
3 Years27.84%
TTM23.15%
EPS CAGR
10 Years11.24%
5 Years14.22%
3 Years27.07%
TTM20.45%
Return on Capital
10 Years16.47%
5 Years17.68%
3 Years21.99%
Last Year17.63%
EHC Recent Earnings
Encompass Health Corporation (EHC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.60+6.0%
$1.51
Rev
$1.6B+1.2%
$1.6B
Q1 2026
Feb 5, 2026Metric
Actual
Est
EPS
$1.46+13.2%
$1.29
Rev
$1.5B+0.3%
$1.5B
Q4 2025
Oct 29, 2025Metric
Actual
Est
EPS
$1.23+3.4%
$1.19
Rev
$1.5B-4.1%
$1.5B
Q3 2025
Aug 4, 2025Metric
Actual
Est
EPS
$1.40+13.8%
$1.23
Rev
$1.5B+2.1%
$1.4B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.60vs $1.51+6.0% | $1.6Bvs $1.6B+1.2% |
| Q1 2026 | Feb 5, 2026 | $1.46vs $1.29+13.2% | $1.5Bvs $1.5B+0.3% |
| Q4 2025 | Oct 29, 2025 | $1.23vs $1.19+3.4% | $1.5Bvs $1.5B-4.1% |
| Q3 2025 | Aug 4, 2025 | $1.40vs $1.23+13.8% | $1.5Bvs $1.4B+2.1% |
Based on last 12 quarters of dataView full earnings history →
EHC Peer Comparison
Encompass Health Corporation (EHC) competitors in Post-acute and senior care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 USPH | 964.39M | 63.32 | 44.59 | 16.33% | 1.52% | 1.36% | 0.55 | |
 SEM | 2.05B | 16.54 | 14.02 | 5.12% | 2.42% | 6.57% | 1.82 | |
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 | |
 ACHC | 2.29B | 24.87 | -2.05 | 5.04% | -32.84% | -40.92% | 1.24 | |
 UHS | 8.84B | 141.17 | 6.11 | 9.71% | 8.56% | 20.65% | 0.74 | |
 THC | 15.12B | 172.57 | 11.14 | 3.12% | 7.94% | 19.56% | 1.47 | |
 HCA | 83.88B | 375.17 | 13.22 | 7.08% | 8.97% | |||
 CYH | 425.61M | 3.02 | 0.80 | -1.18% | -0.41% |
Compare EHC vs Peers
Encompass Health Corporation (EHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
EHC Income Statement
Encompass Health Corporation (EHC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 3.91B | 4.28B | 4.61B | 3.57B | 4.01B | 4.35B | 4.8B | 5.37B | 5.94B | 6.07B |
Revenue Growth % | 7.45% | 9.28% | 7.66% | -22.56% | 12.58% | 8.31% | 10.41% | 11.91% | 10.46% | 10.05% |
Cost of Goods Sold | 149.3M | 158.7M | 167.9M | 171M | 2.31B | 2.6B | 2.82B | 3.14B | 254.4M | 2.5B |
COGS % of Revenue | 3.81% | 3.71% | 3.65% | 4.79% | 57.57% | 59.68% | 58.7% | 58.44% | 4.29% | - |
Gross Profit | 3.76B▲ 0% | 4.12B▲ 9.4% | 4.44B▲ 7.7% | 3.4B▼ 23.5% | 1.7B▼ 49.8% | 1.75B▲ 2.9% | 1.98B▲ 13.1% | 2.23B▲ 12.6% | 5.68B▲ 154.4% | 3.57B▲ 0% |
Gross Margin % | 96.19% | 96.29% | 96.35% | 95.21% | 42.43% | 40.32% | 41.3% | 41.56% | 95.71% | 58.82% |
Gross Profit Growth % | 7.48% | 9.4% | 7.73% | -23.48% | -49.83% | 2.92% | 13.1% | 12.63% | 154.38% | - |
Operating Expenses | 3.76B | 4.12B | 4.44B | 3.4B | 1.04B | 1.12B | 258M | 1.37B | 4.63B | 2.48B |
OpEx % of Revenue | 96.19% | 96.29% | 96.35% | 95.21% | 26% | 25.82% | 5.37% | 25.47% | 77.97% | - |
Selling, General & Admin | 2.4B | 2.65B | 2.9B | 2.12B | 228.5M | 209M | 258M | 266.5M | 3.41B | 1.07B |
SG&A % of Revenue | 61.31% | 62.01% | 63.02% | 59.36% | 5.69% | 4.81% | 5.37% | 4.96% | 57.47% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 1.36B | 1.47B | 1.53B | 1.28B | 815.5M | 914M | 0 | 1.1B | 1.22B | 4M |
Operating Income | 649.4M▲ 0% | 681.6M▲ 5.0% | 692.5M▲ 1.6% | 0▼ 100.0% | 659.4M▲ 0% | 630.2M▼ 4.4% | 1.72B▲ 173.7% | 864.5M▼ 49.9% | 1.05B▲ 21.8% | 1.02B▲ 0% |
Operating Margin % | 16.59% | 15.94% | 15.04% | - | 16.42% | 14.49% | 35.92% | 16.09% | 17.74% | 16.79% |
Operating Income Growth % | 0.09% | 4.96% | 1.6% | -100% | - | -4.43% | 173.69% | -49.88% | 21.82% | - |
EBITDA | 833.2M | 881.3M | 911.2M | 739.6M | 879M | 873.8M | 2B | 1.16B | 1.38B | 1.35B |
EBITDA Margin % | 21.29% | 20.6% | 19.79% | 20.74% | 21.89% | 20.09% | 41.63% | 21.66% | 23.27% | 22.33% |
EBITDA Growth % | 1.44% | 5.77% | 3.39% | -18.83% | 18.85% | -0.59% | 128.74% | -41.76% | 18.63% | 9.89% |
D&A (Non-Cash Add-back) | 183.8M | 199.7M | 218.7M | 203M | 219.6M | 243.6M | 273.9M | 299.6M | 327.9M | 336M |
EBIT | 650.8M | 640.5M | 722M | 536.6M | 669.3M | 626.5M | 731.8M | 887M | 1.08B | 805.8M |
Net Interest Income | -154.4M | -147.3M | -159.7M | -183.7M | -164.3M | -175.7M | -143.5M | -137.4M | -123.2M | -91.4M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 154.4M | 147.3M | 159.7M | 183.7M | 164.3M | 175.7M | 143.5M | 137.4M | 123.2M | 123.2M |
Other Income/Expense | -153M | -188.4M | -130.2M | 352.9M | -154.4M | -179.4M | -1.12B | -114.9M | -100.1M | -15.3M |
Pretax Income | 496.4M▲ 0% | 493.2M▼ 0.6% | 562.3M▲ 14.0% | 352.9M▼ 37.2% | 505M▲ 43.1% | 450.8M▼ 10.7% | 607.2M▲ 34.7% | 749.6M▲ 23.5% | 953M▲ 27.1% | 1B▲ 0% |
Pretax Margin % | 12.68% | 11.53% | 12.21% | 9.9% | 12.58% | 10.37% | 12.65% | 13.95% | 16.06% | 16.54% |
Income Tax | 145.8M | 118.9M | 115.9M | 74.7M | 101.9M | 100.1M | 132.2M | 150.2M | 192.9M | 207.7M |
Effective Tax Rate % | 29.37% | 24.11% | 20.61% | 21.17% | 20.18% | 22.2% | 21.77% | 20.04% | 20.24% | 20.71% |
Net Income | 271.1M▲ 0% | 292.3M▲ 7.8% | 358.7M▲ 22.7% | 284.2M▼ 20.8% | 412.2M▲ 45.0% | 271M▼ 34.3% | 352M▲ 29.9% | 455.7M▲ 29.5% | 566.2M▲ 24.2% | 609.2M▲ 0% |
Net Margin % | 6.93% | 6.83% | 7.79% | 7.97% | 10.27% | 6.23% | 7.33% | 8.48% | 9.54% | 10.04% |
Net Income Growth % | 9.49% | 7.82% | 22.72% | -20.77% | 45.04% | -34.26% | 29.89% | 29.46% | 24.25% | 23.15% |
Net Income (Continuing) | 350.6M | 374.3M | 446.4M | 278.2M | 403.1M | 350.7M | 475M | 599.4M | 760.1M | 757.6M |
Discontinued Operations | -400K | 1.1M | -600K | 90.6M | 114.1M | 15.2M | -12M | -2.8M | -1M | -500K |
Minority Interest | 463.8M | 542M | 580.5M | 413.6M | 487.9M | 551.6M | 649.7M | 782.2M | 837.6M | 58.8M |
EPS (Diluted) | 2.69▲ 0% | 2.93▲ 8.9% | 3.61▲ 23.2% | 2.85▼ 21.1% | 4.11▲ 44.2% | 2.70▼ 34.3% | 3.47▲ 28.5% | 4.46▲ 28.5% | 5.54▲ 24.2% | 6.06▲ 0% |
EPS Growth % | 3.86% | 8.92% | 23.21% | -21.05% | 44.21% | -34.31% | 28.52% | 28.53% | 24.22% | 20.45% |
EPS (Basic) | 2.73 | 2.99 | 3.65 | 2.87 | 4.15 | 2.72 | 3.54 | 4.53 | 5.62 | - |
Diluted Shares Outstanding | 99.3M | 99.8M | 99.4M | 99.8M | 100.2M | 100.4M | 101.3M | 102.2M | 102.2M | 100.6M |
Basic Shares Outstanding | 93.7M | 97.9M | 98M | 98.6M | 99M | 99.2M | 99.5M | 99.9M | 100.5M | 99.2M |
Dividend Payout Ratio | 33.75% | 34.49% | 30.3% | 39.37% | 27.22% | 36.53% | 17.16% | 13.78% | 12.56% | - |
EHC Balance Sheet
Encompass Health Corporation (EHC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 702.2M | 662.1M | 755.8M | 948.6M | 921.4M | 717.2M | 841.8M | 886.9M | 905.9M | 1.03B |
Cash & Short-Term Investments | 54.4M | 69.2M | 94.8M | 224M | 49.4M | 21.8M | 141.8M | 85.4M | 145.1M | 110.5M |
Cash Only | 54.4M | 69.2M | 94.8M | 224M | 49.4M | 21.8M | 104.2M | 85.4M | 102.9M | 110.5M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 37.6M | 0 | 42.2M | 0 |
Accounts Receivable | 472.1M | 467.7M | 498.7M | 563M | 502.1M | 536.8M | 611.6M | 598.8M | 619.2M | 676M |
Days Sales Outstanding | 44.03 | 39.91 | 39.53 | 57.62 | 45.65 | 45.06 | 46.5 | 40.68 | 38.08 | 37.88 |
Inventory | 62.4M | 59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | 152.55 | 135.7 | - | - | - | - | - | - | - | - |
Other Current Assets | 62.4M | 59M | 64.8M | 75.2M | 255M | 123.7M | 53.9M | 160.4M | 87.7M | 242.6M |
Total Non-Current Assets | 4.19B | 4.57B | 5.32B | 5.5B | 5.94B | 4.92B | 5.26B | 5.65B | 6.18B | 6.28B |
Property, Plant & Equipment | 1.52B | 1.63B | 2.24B | 2.45B | 2.77B | 3.15B | 3.51B | 3.85B | 4.31B | 4.42B |
Fixed Asset Turnover | 2.58x | 2.62x | 2.06x | 1.45x | 1.45x | 1.38x | 1.37x | 1.40x | 1.38x | 1.43x |
Goodwill | 1.97B | 2.1B | 2.31B | 2.32B | 1.24B | 1.26B | 1.28B | 1.28B | 1.32B | 1.32B |
Intangible Assets | 403.1M | 443.4M | 476.3M | 431.3M | 158.4M | 282.3M | 278.2M | 297.8M | 308.3M | 300.3M |
Long-Term Investments | 56.1M | 74.2M | 7.4M | 5.5M | 0 | 0 | 109.5M | 122.5M | 129.1M | 224M |
Other Non-Current Assets | 179M | 216.8M | 300.2M | 289.5M | 1.77B | 222.1M | 82.1M | 96.7M | 114.6M | 244.4M |
Total Assets | 4.89B▲ 0% | 5.23B▲ 6.8% | 6.08B▲ 16.3% | 6.45B▲ 6.0% | 6.86B▲ 6.5% | 5.64B▼ 17.9% | 6.1B▲ 8.3% | 6.53B▲ 7.1% | 7.09B▲ 8.5% | 7.31B▲ 0% |
Asset Turnover | 0.80x | 0.82x | 0.76x | 0.55x | 0.58x | 0.77x | 0.79x | 0.82x | 0.84x | 0.86x |
Asset Growth % | 4.52% | 6.82% | 16.32% | 6.01% | 6.5% | -17.89% | 8.27% | 7.08% | 8.49% | 31.13% |
Total Current Liabilities | 517.5M | 672.5M | 721M | 717.3M | 748.8M | 575.9M | 656.4M | 841M | 836.4M | 876.8M |
Accounts Payable | 78.4M | 90M | 94.6M | 115M | 134M | 132.9M | 170M | 171M | 178.2M | 204M |
Days Payables Outstanding | 191.67 | 206.99 | 205.65 | 245.47 | 21.16 | 18.69 | 22.02 | 19.88 | 255.67 | 25.39 |
Short-Term Debt | 32.3M | 35.8M | 18.3M | 14.5M | 18.7M | 25.2M | 48.9M | 114.9M | 70.1M | 69.8M |
Deferred Revenue (Current) | 196.8M | 212.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 149.1M | 292.6M | 162.7M | 174.3M | 264.1M | 181.1M | 230M | 505.1M | 588.1M | 603M |
Current Ratio | 1.36x | 0.98x | 1.05x | 1.32x | 1.23x | 1.25x | 1.28x | 1.05x | 1.08x | 1.17x |
Quick Ratio | 1.24x | 0.90x | 1.05x | 1.32x | 1.23x | 1.25x | 1.28x | 1.05x | 1.08x | 1.17x |
Cash Conversion Cycle | 4.91 | -31.39 | - | - | - | - | - | - | - | 12.49 |
Total Non-Current Liabilities | 2.73B | 2.68B | 3.43B | 3.73B | 3.72B | 3.2B | 3.15B | 2.84B | 2.98B | 3.07B |
Long-Term Debt | 2.55B | 2.48B | 2.63B | 2.85B | 2.85B | 2.74B | 2.37B | 2.06B | 2.18B | 188.7M |
Capital Lease Obligations | 0 | 0 | 634.9M | 605.5M | 568.8M | 199.7M | 514.6M | 484.4M | 464.7M | 1.15B |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 83M | 87M | 105.2M | 126.8M | 480M |
Other Non-Current Liabilities | 185.3M | 205.2M | 159.9M | 266.8M | 296.8M | 174.2M | 177.9M | 190.4M | 206.9M | 2.75B |
Total Liabilities | 3.25B | 3.36B | 4.15B | 4.44B | 4.47B | 3.77B | 3.81B | 3.69B | 3.81B | 3.95B |
Total Debt | 2.58B | 2.51B | 3.35B | 3.54B | 3.48B | 2.99B | 2.93B | 2.71B | 2.71B | 258.5M |
Net Debt | 2.52B | 2.45B | 3.25B | 3.32B | 3.43B | 2.97B | 2.83B | 2.63B | 2.61B | 148M |
Debt / Equity | 1.57x | 1.34x | 1.73x | 1.77x | 1.45x | 1.61x | 1.28x | 0.95x | 0.83x | 0.08x |
Debt / EBITDA | 3.09x | 2.85x | 3.67x | 4.79x | 3.96x | 3.42x | 1.47x | 2.33x | 1.97x | 0.19x |
Net Debt / EBITDA | 3.03x | 2.77x | 3.57x | 4.49x | 3.90x | 3.40x | 1.42x | 2.26x | 1.89x | 0.11x |
Interest Coverage | 4.22x | 4.35x | 4.52x | 2.92x | 4.07x | 3.57x | 5.10x | 6.46x | 8.74x | 6.54x |
Total Equity | 1.65B▲ 0% | 1.87B▲ 13.7% | 1.93B▲ 3.3% | 2B▲ 3.6% | 2.4B▲ 19.9% | 1.86B▼ 22.4% | 2.3B▲ 23.4% | 2.85B▲ 24.0% | 3.28B▲ 15.0% | 3.37B▲ 0% |
Equity Growth % | 54.22% | 13.71% | 3.29% | 3.56% | 19.86% | -22.39% | 23.38% | 24.03% | 14.97% | 68.56% |
Book Value per Share | 16.57 | 18.75 | 19.44 | 20.06 | 23.94 | 18.54 | 22.68 | 27.88 | 32.05 | 33.47 |
Total Shareholders' Equity | 1.18B | 1.33B | 1.35B | 1.59B | 1.91B | 1.31B | 1.65B | 2.07B | 2.44B | 3.31B |
Common Stock | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.2M | 1.2M | 1.2M | 0 |
Retained Earnings | -1.19B | -885.2M | -526.5M | -242.3M | 141.8M | 115.7M | 406.5M | 796.7M | 1.29B | 0 |
Treasury Stock | -418.5M | -427.9M | -492.3M | -497.4M | -521.2M | -536.7M | -547.2M | -577.9M | -722.5M | 0 |
Accumulated OCI | -1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 0 |
Minority Interest | 463.8M | 542M | 580.5M | 413.6M | 487.9M | 551.6M | 649.7M | 782.2M | 837.6M | 58.8M |
EHC Cash Flow Statement
Encompass Health Corporation (EHC) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 657.2M | 762.4M | 635.3M | 704.7M | 715.8M | 705.8M | 850.8M | 1B | 1.18B | 908.2M |
Operating CF Margin % | 16.79% | 17.82% | 13.8% | 19.76% | 17.83% | 16.23% | 17.72% | 18.66% | 19.81% | - |
Operating CF Growth % | 8.54% | 16.01% | -16.67% | 10.92% | 1.58% | -1.4% | 20.54% | 17.87% | 17.23% | -43.14% |
Net Income | 335.8M | 374.3M | 446.4M | 284.2M | 517.6M | 365.9M | 361.6M | 599.4M | 567.2M | 609.2M |
Depreciation & Amortization | 183.8M | 199.7M | 218.7M | 243M | 219.6M | 243.6M | 273.9M | 299.6M | 327.9M | 345.6M |
Stock-Based Compensation | 47.7M | 85.9M | 114.4M | 25.6M | 29.1M | 29.2M | 50.6M | 48.3M | 0 | 58.5M |
Deferred Taxes | 75.6M | -9.1M | 40M | 52.4M | 17.4M | 27.9M | 3.9M | 10.7M | 22.3M | 2.9M |
Other Non-Cash Items | 75.2M | 65.6M | -4.1M | 5.6M | 50.1M | 69.6M | 110.5M | 22.9M | 253.9M | -264.4M |
Working Capital Changes | -60.9M | 46M | -180.1M | 93.9M | -118M | -30.4M | 50.3M | 21.9M | 4.3M | 11.8M |
Change in Receivables | -83.9M | 7M | -22.9M | -5.1M | -64.3M | -16.9M | -22.4M | 3M | -15.2M | -43.7M |
Change in Inventory | 25.9M | -2.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 7.5M | 6.6M | -6.1M | 0 | 14.9M | 2.3M | 11.8M | 3M | -22.6M | -22.5M |
Cash from Investing | -284.5M | -424.5M | -657.4M | -407.5M | -666.3M | -627M | -602.8M | -653.3M | -762.8M | -754.4M |
Capital Expenditures | -245M | -270.5M | -404.1M | -408.2M | -551.2M | -584.1M | -583.1M | -642.5M | -736.4M | -735.7M |
CapEx % of Revenue | 6.26% | 6.32% | 8.78% | 11.45% | 13.73% | 13.43% | 12.14% | 11.96% | 12.41% | 12.13% |
Acquisitions | -38.8M | -143.9M | -231.5M | -1.1M | -118.6M | 64.1M | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 18.5M | -8.4M | -6.5M | -2.1M | 3.5M | -7.7M | 3.3M | -7.2M | -14.8M | -18.3M |
Cash from Financing | -359.9M | -321.2M | 48.2M | -145.9M | -240.1M | -145.7M | -197.2M | -330.6M | -433M | -405.1M |
Debt Issued (Net) | -202.2M | -103.5M | 476M | 215.9M | -59.1M | -498.2M | -83.3M | -242M | -29M | -9M |
Equity Issued (Net) | -57.9M | 0 | -45.9M | -6.1M | -14.6M | -7.3M | -8.2M | -31.1M | -158M | -126M |
Dividends Paid | -91.5M | -100.8M | -108.7M | -111.9M | -112.2M | -99M | -60.4M | -62.8M | -71.1M | -73.4M |
Share Repurchases | -38.1M | -65.6M | -45.9M | -6.1M | -14.6M | -7.3M | -8.2M | -31.1M | -158M | -197.6M |
Other Financing | -8.3M | -116.9M | -273.2M | -243.8M | -54.2M | 458.8M | -45.3M | 5.3M | -174.9M | -196.7M |
Net Change in Cash | 13.9M▲ 0% | 16.7M▲ 20.1% | 26.1M▲ 56.3% | 151.3M▲ 479.7% | -190.6M▼ 226.0% | -66.9M▲ 64.9% | 50.8M▲ 175.9% | 18.9M▼ 62.8% | -20.2M▼ 206.9% | 40.6M▲ 0% |
Free Cash Flow | 412.2M▲ 0% | 491.9M▲ 19.3% | 231.2M▼ 53.0% | 296.5M▲ 28.2% | 164.6M▼ 44.5% | 121.7M▼ 26.1% | 267.7M▲ 120.0% | 360.3M▲ 34.6% | 439.2M▲ 21.9% | 172.5M▲ 0% |
FCF Margin % | 10.53% | 11.5% | 5.02% | 8.31% | 4.1% | 2.8% | 5.58% | 6.71% | 7.4% | 2.84% |
FCF Growth % | 2.38% | 19.34% | -53% | 28.24% | -44.49% | -26.06% | 119.97% | 34.59% | 21.9% | -55.36% |
FCF per Share | 4.15 | 4.93 | 2.33 | 2.97 | 1.64 | 1.21 | 2.64 | 3.53 | 4.30 | 1.71 |
FCF Conversion (FCF/Net Income) | 2.42x | 2.61x | 1.77x | 2.48x | 1.74x | 2.60x | 2.42x | 2.20x | 2.08x | 0.28x |
Interest Paid | 150.5M | 149.6M | 155.7M | 168.4M | 168.4M | 178.4M | 147.7M | 146.8M | 0 | 0 |
Taxes Paid | 96.4M | 115.4M | 104.2M | 34.3M | 131.4M | 51.2M | 109.3M | 164.5M | 0 | 0 |
EHC Key Ratios
Encompass Health Corporation (EHC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 19.99% | 16.62% | 18.86% | 14.45% | 18.73% | 12.72% | 16.93% | 17.71% | 18.49% | 18.86% |
Return on Invested Capital (ROIC) | 11.86% | 12.05% | 10.93% | - | 8.87% | 8.86% | 25.98% | 12.23% | 13.9% | 14.66% |
Gross Margin | 96.19% | 96.29% | 96.35% | 95.21% | 42.43% | 40.32% | 41.3% | 41.56% | 95.71% | 58.82% |
Net Margin | 6.93% | 6.83% | 7.79% | 7.97% | 10.27% | 6.23% | 7.33% | 8.48% | 9.54% | 10.04% |
Debt / Equity | 1.57x | 1.34x | 1.73x | 1.77x | 1.45x | 1.61x | 1.28x | 0.95x | 0.83x | 0.08x |
Interest Coverage | 4.22x | 4.35x | 4.52x | 2.92x | 4.07x | 3.57x | 5.10x | 6.46x | 8.74x | 6.54x |
FCF Conversion | 2.42x | 2.61x | 1.77x | 2.48x | 1.74x | 2.60x | 2.42x | 2.20x | 2.08x | 0.28x |
Revenue Growth | 7.45% | 9.28% | 7.66% | -22.56% | 12.58% | 8.31% | 10.41% | 11.91% | 10.46% | 10.05% |
Related:EHC Dividend History·EHC Revenue History·EHC Price History·EHC P/E History·EHC Financial Ratios·EHC Institutional Holders
EHC SEC Filings & Documents
Encompass Health Corporation (EHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
EHC Frequently Asked Questions
Encompass Health Corporation (EHC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Encompass Health Corporation (EHC) reported $6.07B in revenue for fiscal year 2025. This represents a 129% increase from $2.65B in 1996.
Encompass Health Corporation (EHC) grew revenue by 10.5% over the past year. This is steady growth.
Yes, Encompass Health Corporation (EHC) is profitable, generating $609.2M in net income for fiscal year 2025 (9.5% net margin).
Dividend & Returns
Yes, Encompass Health Corporation (EHC) pays a dividend with a yield of 0.71%. This makes it attractive for income-focused investors.
Encompass Health Corporation (EHC) has a return on equity (ROE) of 18.5%. This is reasonable for most industries.
Encompass Health Corporation (EHC) generated $172.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.